Urolog. pro Praxi, 2002; 6: 263-266
Extrakt z Pygeum africanum v terapii benigní hyperplazie prostaty
- Urologická klinika FN a LF UK Hradec Králové
Keywords: Pygeum africanum, benign hyperplasia of prostate.
Published: December 31, 2002 Show citation
V rámci doktorandské práce byl sestaven soubor mužů se symptomy benigní hyperplazie prostaty. Objektivizace symptomů byla provedena pomocí mezinárodního prostatického skóre (IPSS) se stanovením kvality života (QoL), uroflowmetrie (UFM), vyšetření per rectum (DRE), transrektální sonografie (TRUS) a hladiny PSA. Soubor 300 mužů byl rozdělen do šesti skupin po 50 mužích tak, aby byly statisticky srovnatelné. Každá skupina mužů užívala některé z léčiv registrovaných k terapii BHP. Autor referuje o skupině mužů léčených extraktem z Pygeum africanum (Tadenan).
Extract of Pygeum africanum for the treatment of benign prostatic hyperplasia
Within the PhD study a group of men with symptoms of benign prostatic hyperplasia was established. The objectification of symptoms was evaluated applying international prostatic score (IPSS) with assessment of quality of life (QoL), by performing uroflowmetry (UFM), digital rectal examination (DRE), transrectal ultrasonography (TRUS) and by determination of PSA levels. The group of 300 men was divided into 6 subgroups of 50 men in order to be statistically comparable. Each group was treated by one of registered drugs for therapy of BPH. The author reports on the group of men treated with the extract of Pygeum africanum (Tadenan).
Download citation
References
- Abrams P, Schulman CC, et al. Tamsulosin, a selective alpha 1c-adrenoceptor antagonist: a randomized, controlled trial in patients with benign prostatic, obstruction' (symptomatic BPH). The European Tamsulosin Study Group. Br J Urol, 1995; 76 (3): 325-336.
Go to original source... 
Go to PubMed... - Andro MC, Riffaud JP. Pygeum africanum Extract for the Treatment of Patients with Benign Prostatic Hyperplasia: A Review of 25 Years of Published Experience. Current Therapeutic Research, 1995; 56 (8): 796-817. Go to original source...
- Bombardelli E, Morazzoni P. Prunus africana (Hook. f.) Kalkm. Fitotherapia, 1997; 68 (3): 205-218.
- Breza J, Dzurny O, et al. Efficacy and acceptability of Tadenan (Pygeum africanum extract) in the treatment of benign prostatic hyperplasia (BHP): a multicentre trial in central Europe. Curr Med Res Opin, 1998; 14 (3): 127-139. Go to original source... Go to PubMed...
- Debruyne FM, Van der Poel HG. Clinical experience in europe with uroselective alpha1-antagonists. Eur Urol, 1999; 36 (Suppl 1): 54-58. Go to original source... Go to PubMed...
- Djavan B, Marberger M. A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction. Eur Urol, 1999; 36 (1): 1-13. Go to original source... Go to PubMed...
- Chapple CR, Baert L, et al. Tamsulosin 0.4 mg once daily: tolerability in older and younger patients with lower urinary tract symptoms suggestive of benign prostatic obstruction (symptomatic BPH). The European Tamsulosin Study Group. Eur Urol, 1997; 32 (4): 462-470. Go to original source... Go to PubMed...
- Michell MC, Mehlburger L, et al. Tamsulosin treatment of 19,365 patients with lower urinary tract symptoms: does co-morbidity alter tolerability? Published erratum appears in J Urol 1998; 160 (6 Pt 1): 2164. Go to original source... Go to PubMed...
- Wilt TJ, MacDonald R, et al. beta-sitosterol for the treatment of benign prostatic hyperplasia: a systematic review. BJU Int 1999; 83 (9): 976-983. Go to original source... Go to PubMed...